SOA
BLACR

Sea Otter Advisors’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Sea Otter Advisors’s Portfolio BLACR Stock Details BLACR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-122,000
Closed -$17.1K – 54
2024
Q1 		$17.1K Buy
+122,000
New +$18.6K 0.08% 51
2023
Q4 		– Sell
-122,000
Closed -$28.1K – 230
2023
Q3 		$28.1K Hold
122,000
– – 0.02% 140
2023
Q2 		$23.3K Sell
122,000
-22,900
-16% -$3.99K 0.01% 154
2023
Q1 		$26.1K Buy
+144,900
New +$22.5K 0.01% 164

Other funds holding BLACR

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Sea Otter Advisors's BLACR Position: Q2 2024 in Review

Sea Otter Advisors sold out of Bellevue Life Sciences Acquisition Corp. Rights (BLACR) in Q2 2024, closing a stake of 122,000 shares — an estimated $17.1K sold.

Sea Otter Advisors first reported a position in BLACR in Q1 2023 and held it in 4 quarters. The position peaked at $28.1K in Q3 2023. 30 funds tracked by Wall St. Rank hold BLACR as of Q2 2024.

  • Sea Otter Advisors reported no remaining Bellevue Life Sciences Acquisition Corp. Rights position as of Q2 2024 after selling out during the quarter.
  • Sea Otter Advisors sold 122,000 Bellevue Life Sciences Acquisition Corp. Rights shares in Q2 2024, an estimated $17.1K.
  • Sea Otter Advisors first reported a position in Bellevue Life Sciences Acquisition Corp. Rights in Q1 2023 and held it in 4 quarters.
  • Sea Otter Advisors's Bellevue Life Sciences Acquisition Corp. Rights position peaked at $28.1K in Q3 2023.
  • 30 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Rights as of Q2 2024.

Based on Sea Otter Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.